Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (91-100 of 237) with videos related to

Pageof 24
Sort By:
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
The British Journal of Ophthalmology|June 11, 2017
Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 yearsLarissa A Habib, Jasmine H Francis, Armida Wm Fabius, et al.
Journal of Neuro-Oncology|June 8, 2010
Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivorsStephen A Sands, Keith P Pasichow, Rebecca Weiss, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 13, 2016
Meningioma after radiotherapy for malignancyPeter F Morgenstern, Kalee Shah, Ira J Dunkel, et al.
The British Journal of Ophthalmology|November 22, 2005
Systemic carboplatin for retinoblastoma: change in tumour size over timeD H Abramson, S D Lawrence, K L Beaverson, et al.
Pediatric Blood & Cancer|May 7, 2011
Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivorsPooja Bhagia, Agnes Basas Colanta, David H Abramson, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2002
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescueJohn A Heath, Emmett H Broxson, Mukund G Dole, et al.
The Open Ophthalmology Journal|February 1, 2012
Intraocular hemorrhage after intra-arterial chemotherapy for retinoblastoma in sickle cell traitDavid H Abramson, Brian P Marr, Scott E Brodie, et al.
The Oncologist|January 28, 2012
Characteristics of oral mucosal events related to bevacizumab treatmentIgor T Gavrilovic, Yevgeniy Balagula, Alyx C Rosen, et al.
Plos One|October 11, 2014
Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastomaIra J Dunkel, Weiji Shi, Kim Salvaggio, et al.
Pageof 24

Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
The British Journal of Ophthalmology|June 11, 2017
Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 yearsLarissa A Habib, Jasmine H Francis, Armida Wm Fabius, et al.
Journal of Neuro-Oncology|June 8, 2010
Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivorsStephen A Sands, Keith P Pasichow, Rebecca Weiss, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 13, 2016
Meningioma after radiotherapy for malignancyPeter F Morgenstern, Kalee Shah, Ira J Dunkel, et al.
The British Journal of Ophthalmology|November 22, 2005
Systemic carboplatin for retinoblastoma: change in tumour size over timeD H Abramson, S D Lawrence, K L Beaverson, et al.
Pediatric Blood & Cancer|May 7, 2011
Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivorsPooja Bhagia, Agnes Basas Colanta, David H Abramson, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2002
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescueJohn A Heath, Emmett H Broxson, Mukund G Dole, et al.
The Open Ophthalmology Journal|February 1, 2012
Intraocular hemorrhage after intra-arterial chemotherapy for retinoblastoma in sickle cell traitDavid H Abramson, Brian P Marr, Scott E Brodie, et al.
The Oncologist|January 28, 2012
Characteristics of oral mucosal events related to bevacizumab treatmentIgor T Gavrilovic, Yevgeniy Balagula, Alyx C Rosen, et al.
Plos One|October 11, 2014
Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastomaIra J Dunkel, Weiji Shi, Kim Salvaggio, et al.
Pageof 24